首页 | 本学科首页   官方微博 | 高级检索  
检索        

黄花倒水莲降血脂活性成分研究
引用本文:徐康平,黄伟,谭健兵,周应军,李福双,黄朝辉,刘保川,谭桂山.黄花倒水莲降血脂活性成分研究[J].中药材,2006,29(1):16-19.
作者姓名:徐康平  黄伟  谭健兵  周应军  李福双  黄朝辉  刘保川  谭桂山
作者单位:1. 中南大学药学院药物化学系,湖南,长沙,410013
2. 中南大学药学院药物化学系,湖南,长沙,410013;中南大学湘雅医院药剂科,湖南,长沙,410008
基金项目:湖南省科技厅科技攻关项目
摘    要:从黄花倒水莲Polygala fallaxHem sl.根的降血脂有效部位中分离得到四个皂苷类化合物,分别鉴定为3-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyl presenegen in 28-O-β-D-xylopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)--βD-fucopyransoyl ester(Ⅰ)、3-O--βD-glucopyranosyl-(1→2)--βD-glucopyranosyl presenegen in 28-O-β-D-xy-lopyranosyl-(1→4)-α-L-rhamnopyranosyl-(1→2)-(3-O-acetyl)-β-D-fucopyranosyl ester(Ⅱ)、3-O-β-D-glucopyranosyl-(1→2)-β-D-glucopyranosyl presenegen in 28-O-β-D-xylopyranosyl-(1→4)--αL-rhamnopyranosyl-(1→2)-(4-O-acetyl)-β-D-fucopyranosyl ester(Ⅲ)和3-O-β-D-glucopyranosyl-(1→2)--βD-glucopyranosyl presenegen in 28-O-β-D-xylopyrano-syl-(1→4)-α-L-rhamnopyranosyl-(1→2)-(3,4-d iacetyl)--βD-fucopyranosyl ester(Ⅳ)。

关 键 词:黄花倒水莲  皂苷
文章编号:1001-4454(2006)01-0016-04
收稿时间:2005-09-07
修稿时间:2005年9月7日

Study on the Antihyperlipidemia Effective Constituent of Polygala fallax Hemsl.
XU Kang-ping,HUANG Wei,TAN Jian-bin,ZHOU Ying-jun,LI Fu-shuang,HUANG Zhao-hui,LIU Bao-chuan,TAN Gui-shan.Study on the Antihyperlipidemia Effective Constituent of Polygala fallax Hemsl.[J].Jorunal of Chinese Medicinal Materials,2006,29(1):16-19.
Authors:XU Kang-ping  HUANG Wei  TAN Jian-bin  ZHOU Ying-jun  LI Fu-shuang  HUANG Zhao-hui  LIU Bao-chuan  TAN Gui-shan
Institution:1. Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Central South University, Changsha 410013, China; 2. Department of Pharmacy, Xiangya Hospital, Central South University, Changsha 410008, China
Abstract:OBJECTIVE: To study the antihyperlipidemia effective constituent of Polygala fallax Hemsl. METHOD: Column chromatographic techniques were employed for isolation and purification of chemical constituents of the plant and the structures were elucidated by IR, NMR and MS spectroscopy. RESULT: Four triterpenoid saponins were isolated and determined as 3-O-beta-D-glucopyranosyl-( 1--> 2) -beta-D-glucopyranosyl presenegenin 28-O-beta-D-xylopyranosyl-(1-->4 ) -alpha-L-rhamnopyranosyl-(1-->2 ) -beta-D-fucopyranosyl ester (I), 3-O-beta-D-glucopyranosyl-(1-->2) -beta-D-glucopyranosyl presenegenin 28-O-beta-D-xylopyranosyl-(1-->4) -alpha-L-rhamnopyranosyl-(1-->2) -(3-O-acetyl)-beta-D-fucopyranosyl ester (II), 3-O-beta-D-glucopyranosyl-(1-->2) -beta-D-glucopyranosyl presenegenin 28-O-beta-D-xylopyranosyl-(1-->4) -alpha-L-rhamnopyranosyl-(1-->2) -(4-O-acetyl) -beta-D-fucopyranosyl ester (II) and 3-O-beta-D-glucopyranosyl-(1--2) -beta-D-glucopyranosyl presenegenin 28-O-beta-D-xylopyranosyl-(1-->4 ) -alpha-L-rhamnopyranosyl-(1-->2 ) - (3,4-diacetyl) -beta-D-fucopyranosyl ester (IV). CONCLUSIONS: The effective constituents of Polygala fallax Hemsl. reduced blood lipid especially plasma TG markedly. The authors have studied the chemical constituents of effective constituent systematically for the first time.
Keywords:Polygala fallax Hemsl    Triterpenoid saponins  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号